ЕЛЬТРОМБОПАГ-ВІСТА
Analogs of ЕЛЬТРОМБОПАГ-ВІСТА
Find cheaper analogs and generic equivalents for ЕЛЬТРОМБОПАГ-ВІСТА.
Active Ingredient: Eltrombopag
Product Overview
About ЕЛЬТРОМБОПАГ-ВІСТА
ЕЛЬТРОМБОПАГ-ВІСТА is a prescription medication containing the active ingredient Eltrombopag, used to treat low platelet count (thrombocytopenia) in patients with chronic immune thrombocytopenia (ITP) and to reduce the risk of bleeding in patients with chronic liver disease who are undergoing procedures.
Key Benefits & Uses
- Treatment of low platelet count (thrombocytopenia) in patients with chronic immune thrombocytopenia (ITP)
- Reduction of the risk of bleeding in patients with chronic liver disease who are undergoing procedures
Active Ingredient & Action
Eltrombopag works by stimulating the production of platelets in the bone marrow, helping to increase platelet counts and reduce the risk of bleeding. It is a thrombopoietin receptor agonist that binds to the thrombopoietin receptor on the surface of platelet-producing cells, triggering a response that leads to increased platelet production.
Important Notes
ЕЛЬТРОМБОПАГ-ВІСТА should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and treatment schedule to minimize the risk of side effects. Patients with a history of blood clots or other bleeding disorders should discuss their individual risk factors with their doctor before starting treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
